Evaluation of pharmacokinetics and the stability of daptomycin in serum at various temperatures

Chika Ogami, Yasuhiro Tsuji, Hidefumi Kasai, Yoichi Hiraki, Yoshihiro Yamamoto, Kazuhisa Matsunaga, Yoshiharu Karube, Hideto To

Research output: Contribution to journalArticle

3 Citations (Scopus)

Abstract

Background Daptomycin exhibits concentration-dependent antibacterial activity. By monitoring daptomycin serum concentrations, clinicians may be able to predict the effectiveness of treatments for infections more accurately. However, it has been reported that daptomycin concentrations in plasma samples stored at −20 °C decrease approximately 25% after 4 weeks. The aim of this study was to evaluate the stability of daptomycin in serum at various temperatures. Methods Daptomycin serum samples were prepared and stored at different temperatures. The stability of daptomycin under various conditions was evaluated by sequential measurements of concentration. Results Although the loss of concentration of daptomycin in serum samples stored in freezers (−80 °C and −20 °C) was less than 10% after 168 days (6 months), the concentrations in samples stored in a refrigerator (4 °C) decreased by more than 70% over the same period. Furthermore, daptomycin concentrations in serum samples stored at close to body temperature (35 °C, 37 °C, and 39 °C) decreased by more than 50% after only 24 h. Conclusions The results of the present study demonstrate that the measurement of serum concentrations of daptomycin needs to be performed rapidly. Furthermore, the degradation of daptomycin in serum may be involved in its elimination from the living body.

Original languageEnglish
Pages (from-to)38-43
Number of pages6
JournalInternational Journal of Infectious Diseases
Volume57
DOIs
Publication statusPublished - 2017 Apr 1
Externally publishedYes

Fingerprint

Daptomycin
Pharmacokinetics
Temperature
Serum
Body Temperature

Keywords

  • Daptomycin
  • Protease
  • Stability
  • Therapeutic drug monitoring

ASJC Scopus subject areas

  • Microbiology (medical)
  • Infectious Diseases

Cite this

Evaluation of pharmacokinetics and the stability of daptomycin in serum at various temperatures. / Ogami, Chika; Tsuji, Yasuhiro; Kasai, Hidefumi; Hiraki, Yoichi; Yamamoto, Yoshihiro; Matsunaga, Kazuhisa; Karube, Yoshiharu; To, Hideto.

In: International Journal of Infectious Diseases, Vol. 57, 01.04.2017, p. 38-43.

Research output: Contribution to journalArticle

Ogami, Chika ; Tsuji, Yasuhiro ; Kasai, Hidefumi ; Hiraki, Yoichi ; Yamamoto, Yoshihiro ; Matsunaga, Kazuhisa ; Karube, Yoshiharu ; To, Hideto. / Evaluation of pharmacokinetics and the stability of daptomycin in serum at various temperatures. In: International Journal of Infectious Diseases. 2017 ; Vol. 57. pp. 38-43.
@article{805a2bc5d75d4d67878d14a9f5afadf2,
title = "Evaluation of pharmacokinetics and the stability of daptomycin in serum at various temperatures",
abstract = "Background Daptomycin exhibits concentration-dependent antibacterial activity. By monitoring daptomycin serum concentrations, clinicians may be able to predict the effectiveness of treatments for infections more accurately. However, it has been reported that daptomycin concentrations in plasma samples stored at −20 °C decrease approximately 25{\%} after 4 weeks. The aim of this study was to evaluate the stability of daptomycin in serum at various temperatures. Methods Daptomycin serum samples were prepared and stored at different temperatures. The stability of daptomycin under various conditions was evaluated by sequential measurements of concentration. Results Although the loss of concentration of daptomycin in serum samples stored in freezers (−80 °C and −20 °C) was less than 10{\%} after 168 days (6 months), the concentrations in samples stored in a refrigerator (4 °C) decreased by more than 70{\%} over the same period. Furthermore, daptomycin concentrations in serum samples stored at close to body temperature (35 °C, 37 °C, and 39 °C) decreased by more than 50{\%} after only 24 h. Conclusions The results of the present study demonstrate that the measurement of serum concentrations of daptomycin needs to be performed rapidly. Furthermore, the degradation of daptomycin in serum may be involved in its elimination from the living body.",
keywords = "Daptomycin, Protease, Stability, Therapeutic drug monitoring",
author = "Chika Ogami and Yasuhiro Tsuji and Hidefumi Kasai and Yoichi Hiraki and Yoshihiro Yamamoto and Kazuhisa Matsunaga and Yoshiharu Karube and Hideto To",
year = "2017",
month = "4",
day = "1",
doi = "10.1016/j.ijid.2017.01.017",
language = "English",
volume = "57",
pages = "38--43",
journal = "International Journal of Infectious Diseases",
issn = "1201-9712",
publisher = "Elsevier",

}

TY - JOUR

T1 - Evaluation of pharmacokinetics and the stability of daptomycin in serum at various temperatures

AU - Ogami, Chika

AU - Tsuji, Yasuhiro

AU - Kasai, Hidefumi

AU - Hiraki, Yoichi

AU - Yamamoto, Yoshihiro

AU - Matsunaga, Kazuhisa

AU - Karube, Yoshiharu

AU - To, Hideto

PY - 2017/4/1

Y1 - 2017/4/1

N2 - Background Daptomycin exhibits concentration-dependent antibacterial activity. By monitoring daptomycin serum concentrations, clinicians may be able to predict the effectiveness of treatments for infections more accurately. However, it has been reported that daptomycin concentrations in plasma samples stored at −20 °C decrease approximately 25% after 4 weeks. The aim of this study was to evaluate the stability of daptomycin in serum at various temperatures. Methods Daptomycin serum samples were prepared and stored at different temperatures. The stability of daptomycin under various conditions was evaluated by sequential measurements of concentration. Results Although the loss of concentration of daptomycin in serum samples stored in freezers (−80 °C and −20 °C) was less than 10% after 168 days (6 months), the concentrations in samples stored in a refrigerator (4 °C) decreased by more than 70% over the same period. Furthermore, daptomycin concentrations in serum samples stored at close to body temperature (35 °C, 37 °C, and 39 °C) decreased by more than 50% after only 24 h. Conclusions The results of the present study demonstrate that the measurement of serum concentrations of daptomycin needs to be performed rapidly. Furthermore, the degradation of daptomycin in serum may be involved in its elimination from the living body.

AB - Background Daptomycin exhibits concentration-dependent antibacterial activity. By monitoring daptomycin serum concentrations, clinicians may be able to predict the effectiveness of treatments for infections more accurately. However, it has been reported that daptomycin concentrations in plasma samples stored at −20 °C decrease approximately 25% after 4 weeks. The aim of this study was to evaluate the stability of daptomycin in serum at various temperatures. Methods Daptomycin serum samples were prepared and stored at different temperatures. The stability of daptomycin under various conditions was evaluated by sequential measurements of concentration. Results Although the loss of concentration of daptomycin in serum samples stored in freezers (−80 °C and −20 °C) was less than 10% after 168 days (6 months), the concentrations in samples stored in a refrigerator (4 °C) decreased by more than 70% over the same period. Furthermore, daptomycin concentrations in serum samples stored at close to body temperature (35 °C, 37 °C, and 39 °C) decreased by more than 50% after only 24 h. Conclusions The results of the present study demonstrate that the measurement of serum concentrations of daptomycin needs to be performed rapidly. Furthermore, the degradation of daptomycin in serum may be involved in its elimination from the living body.

KW - Daptomycin

KW - Protease

KW - Stability

KW - Therapeutic drug monitoring

UR - http://www.scopus.com/inward/record.url?scp=85013152628&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85013152628&partnerID=8YFLogxK

U2 - 10.1016/j.ijid.2017.01.017

DO - 10.1016/j.ijid.2017.01.017

M3 - Article

C2 - 28131728

AN - SCOPUS:85013152628

VL - 57

SP - 38

EP - 43

JO - International Journal of Infectious Diseases

JF - International Journal of Infectious Diseases

SN - 1201-9712

ER -